Kaori Shinjo - Concepedia

Author

Kaori Shinjo

Hamamatsu University School of Medicine

Also Known As

K Shinjo, K. Shinjo, KAORI SHINJO, Kaori SHINJO, Kaori Shinjo, K Naito

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Hamamatsu University School of Medicine Aichi Cancer Center Nagoya University Hamamatsu University Hamamatsu Medical Center

About

Kaori Shinjo is an author at Hamamatsu University School of Medicine specializing in medicine, hematology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	932
2	Cell Biology	11	11	258
3	Health Sciences	3	3	367
4	Natural Sciences	1	1	18
5	Biochemistry	1	1	18

Kaori Shinjo

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines Kensuke Naito, Akihiro Takeshita, Kohichiro Shigeno, Leukemia Hematological MalignancyCytocidal EffectP-glycoprotein-expressing SublinesMedicineHematology	2000	152
Arsenic Trioxide Therapy in Relapsed or Refractory Japanese Patients with Acute Promyelocytic Leukemia: Updated Outcomes of the Phase II Study and Postremission Therapies Kazuyuki Shigeno, Kensuke Naito, Miki Kobayashi, International Journal of Hematology Hematological MalignancyOncologyHematologyRefractory Japanese PatientsArsenic Trioxide Therapy	2005	111
Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers Hirotaka Matsui, Akihiro Takeshita, Kensuke Naito, Leukemia Hematological MalignancyGemtuzumab OzogamicinHealth SciencesMultidrug Resistance ModifiersMedicine	2002	104
Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring Kazunori Ohnishi, Hitoshi Yoshida, Kohichiro Shigeno, Leukemia Careful Electrocardiogram MonitoringHematologyRefractory Japanese PatientsArsenic Trioxide TherapyEmergency Medicine	2002	99
Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide Shinya Fujisawa, Ryuzo Ohno, Kazuyuki Shigeno, Cancer Chemotherapy and Pharmacology Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaPharmacologyHematology	2006	64
CMC‐544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B‐cell chronic lymphocytic leukaemia and lymphoma Akihiro Takeshita, Kaori Shinjo, Nozomi Yamakage, British Journal of Haematology Mdr ModifiersImmunologyPathologyImmunotherapyTumor Biology	2009	63
Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells Akihiro Takeshita, Kaori Shinjo, Kensuke Naito, Leukemia Hematological MalignancyOncologyGemtuzumab OzogamicinMedicineMixed-phenotype Acute Leukemia	2005	62
Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia Kaori Shinjo, Akihiro Takeshita, Shota Nakamura, Leukemia Platelet CountsThrombosisThrombopoiesisBlood PlateletChemotherapy-induced Thrombocytopenia	1998	54
Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias Kazuyuki Shigeno, Hitoshi Yoshida, Ling Pan, Cancer Letters Hematological MalignancyChromatinTranscriptional RegulationGeneticsCancer Genetics	2003	42
Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells Mitsuaki Yanagi, Kaori Shinjo, Akihiro Takeshita, Leukemia Hematological MalignancyChromatinChronic Myeloid LeukemiaPhiladelphia Chromosome-positive CellsInterphase Fluorescence	1999	42

Page 1